IRIS

High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib

Romano, Alessandra;
2014-01-01
2014
BLIMP1
IRF4
XBP1
bortezomib
multiple myeloma biomarker
Aged
Antineoplastic Agents
Biomarkers, Tumor
Boronic Acids
Bortezomib
DNA-Binding Proteins
Disease-Free Survival
Female
Gene Expression Regulation, Neoplastic
Humans
Male
Neoplasm Proteins
Pyrazines
Regulatory Factor X Transcription Factors
Survival Rate
Transcription Factors
X-Box Binding Protein 1
Multiple Myeloma
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/542317
Citazioni
  • ???jsp.display-item.citation.pmc??? 23
  • Scopus 41
  • ???jsp.display-item.citation.isi??? 41
social impact